Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dunn

Showing results (781-790 of 851) with videos related to

Pageof 86
Sort By:
Oncogene|January 20, 2009
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cellsM R Finkbeiner, A Astanehe, K To, et al.
Breast Cancer Research : BCR|September 19, 2007
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapyAnna L Stratford, Golareh Habibi, Arezoo Astanehe, et al.
Blood Advances|January 31, 2024
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphomaEsther H Nie, Yi-Jiun Su, John H Baird, et al.
Cell Communication and Signaling : CCS|October 10, 2013
Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activitiesClaudia R C van Roeyen, Florian G Scurt, Sabine Brandt, et al.
JAMA Pediatrics|January 21, 2025
Outcomes of a Population-Based Congenital Cytomegalovirus Screening ProgramJessica K E Dunn, Pranesh Chakraborty, Emily Reuvers, et al.
Cell Reports|October 7, 2020
Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune EncephalomyelitisVahid Hoghooghi, Alexandra L Palmer, Ariana Frederick, et al.
Chemmedchem|July 8, 2023
Expansion of a Synthesized Library of N-Benzyl Sulfonamides Derived from an Indole Core to Target Pancreatic CancerMegan D Hopkins, Ian J Costello, Zachary C Brandeburg, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Ebiomedicine|August 31, 2019
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheresDean Nehama, Natalia Di Ianni, Silvia Musio, et al.
Cancer Research|March 25, 2010
Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistanceKaren To, Abbas Fotovati, Kristen M Reipas, et al.
Pageof 86

Showing results (781-790 of 851) with videos related to

Sort By:
Pageof 86
Oncogene|January 20, 2009
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cellsM R Finkbeiner, A Astanehe, K To, et al.
Breast Cancer Research : BCR|September 19, 2007
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapyAnna L Stratford, Golareh Habibi, Arezoo Astanehe, et al.
Blood Advances|January 31, 2024
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphomaEsther H Nie, Yi-Jiun Su, John H Baird, et al.
Cell Communication and Signaling : CCS|October 10, 2013
Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activitiesClaudia R C van Roeyen, Florian G Scurt, Sabine Brandt, et al.
JAMA Pediatrics|January 21, 2025
Outcomes of a Population-Based Congenital Cytomegalovirus Screening ProgramJessica K E Dunn, Pranesh Chakraborty, Emily Reuvers, et al.
Cell Reports|October 7, 2020
Cystatin C Plays a Sex-Dependent Detrimental Role in Experimental Autoimmune EncephalomyelitisVahid Hoghooghi, Alexandra L Palmer, Ariana Frederick, et al.
Chemmedchem|July 8, 2023
Expansion of a Synthesized Library of N-Benzyl Sulfonamides Derived from an Indole Core to Target Pancreatic CancerMegan D Hopkins, Ian J Costello, Zachary C Brandeburg, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Ebiomedicine|August 31, 2019
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheresDean Nehama, Natalia Di Ianni, Silvia Musio, et al.
Cancer Research|March 25, 2010
Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistanceKaren To, Abbas Fotovati, Kristen M Reipas, et al.
Pageof 86